Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAjantapharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to
    • Buy TCS, JSW Steel, Torrent Pharma, Ajanta Pharma: Gujral

      Buy TCS, JSW Steel, Torrent Pharma, Ajanta Pharma: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying TCS, JSW Steel, Torrent Pharma and Ajanta Pharma.

    • Buy LIC Housing Finance, Ajanta Pharma, Biocon: Ashwani Gujral

      Buy LIC Housing Finance, Ajanta Pharma, Biocon: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying LIC Housing Finance, Ajanta Pharma and Biocon.

    • Prefer Ajanta Pharma: Sudarshan Sukhani

      Prefer Ajanta Pharma: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may prefer Ajanta Pharma from the pharma space.

    • Cadila Healthcare may test Rs 250-260: Ashwani Gujral

      Cadila Healthcare may test Rs 250-260: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that Cadila Healthcare may test Rs 250-260.

    • Buy Ajanta Pharma on dips, short PC Jeweller: Sudarshan Sukhani

      Buy Ajanta Pharma on dips, short PC Jeweller: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Ajanta Pharma on dips and advises shorting PC Jeweller.

    • Buy Ajanta Pharma, SRF: Ashwani Gujral

      Buy Ajanta Pharma, SRF: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Ajanta Pharma and SRF.

    • Buy HDFC, Asian Paints, Ajanta Pharma, Biocon, Britannia: Gujral

      Buy HDFC, Asian Paints, Ajanta Pharma, Biocon, Britannia: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying HDFC, Asian Paints, Ajanta Pharma, Biocon and Britannia Industries.

    • Buy Ajanta Pharma, DHFL, REC, Britannia, SKS Micro: Gujral

      Buy Ajanta Pharma, DHFL, REC, Britannia, SKS Micro: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Ajanta Pharma, DHFL, REC, Britannia and SKS Microfinance.

    • Prefer Aurobindo, Ajanta Pharma, Torrent Pharma: Gujral

      Prefer Aurobindo, Ajanta Pharma, Torrent Pharma: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may prefer Aurobindo Pharma, Ajanta Pharma and Torrent Pharma and likes Glenmark Pharma.

    • Buy Ajanta Pharma, prefer Jubilant Life: Sudarshan Sukhani

      Buy Ajanta Pharma, prefer Jubilant Life: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Ajanta Pharma and prefers Jubilant Lifesciences.

    • Buy Biocon, UltraTech Cement: Sudarshan Sukhani

      Buy Biocon, UltraTech Cement: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Biocon and UltraTech Cement.

    • Buy Ajanta Pharma, Aurobindo Pharma, NCC: Ashwani Gujral

      Buy Ajanta Pharma, Aurobindo Pharma, NCC: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Ajanta Pharma, Aurobindo Pharma and NCC.

    • Sell Ajanta Pharma, Indian Oil Corporation, PNB: Ashwani Gujral

      Sell Ajanta Pharma, Indian Oil Corporation, PNB: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends selling Ajanta Pharma, Indian Oil Corporation and PNB.

    • Go long in Ajanta Pharma, says Rajat Bose

      Go long in Ajanta Pharma, says Rajat Bose

      Rajat Bose of rajatkbose.com recommends going long in Ajanta Pharma.

    • Buy Ajanta Pharma, advises Sudarshan Sukhani

      Buy Ajanta Pharma, advises Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Ajanta Pharma, Cadila Healthcare and Dishman Pharmaceutical.

    • Buy Castrol; HCL Tech may hit Rs 795, Dr Reddy's Rs 2900: Gaba

      Buy Castrol; HCL Tech may hit Rs 795, Dr Reddy's Rs 2900: Gaba

      Prakash Gaba of prakashgaba.com recommends buying Castrol India and feels that HCL Tech may hit Rs 795 while Dr Reddy's Labs may test Rs 2900.

    • Check Out: Super Six stocks for February 25

      Check Out: Super Six stocks for February 25

      Ashish Kyal of wavesstrategy.com is of the view that one may sell Bharat Heavy Electricals with a target of Rs 84.

    • Bull's Eye: Buy IGL, Tata Chemicals; sell Bata, HDIL, Axis Bank

      Bull's Eye: Buy IGL, Tata Chemicals; sell Bata, HDIL, Axis Bank

      Manish Sharma of derivativetradingresearch.com is of the view that one may sell Bata India with a target of Rs 430.

    • 6 trading stocks for short term gain

      6 trading stocks for short term gain

      Hemen Kapadia of KRChoksey Securities advises buying Ajanta Pharma with a target of Rs 1258.

    • Super Six trading ideas for the day

      Super Six trading ideas for the day

      Rakesh Bansal of RK Global recommends selling Ajanta Pharma with a target of Rs 1160 and Bharat Electronics Limited with a target of Rs 1000.

    • Sell BPCL; buy SBI, Axis Bank on dips: Ashwani Gujral

      Sell BPCL; buy SBI, Axis Bank on dips: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends selling BPCL and advises buying State Bank of India and Axis Bank on dips.

    • Sell Ajanta Pharma; buy Container Corp: Ashwani Gujral

      Sell Ajanta Pharma; buy Container Corp: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Container Corporation of India and advises selling Ajanta Pharma.

    • Bull's Eye: Buy SKS Micro, Bharat Forge, Havells, Marico, IOC

      Bull's Eye: Buy SKS Micro, Bharat Forge, Havells, Marico, IOC

      Vishal Malkan of malkansview.com recommends buying SKS Microfinance with a target of Rs 525 and IndusInd Bank with a target of Rs 850.

    • Sell CESC, HPCL; UPL may head lower: Sudarshan Sukhani

      Sell CESC, HPCL; UPL may head lower: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends selling CESC and HPCL and feels that UPL may head lower.

    • Bull's Eye: Buy CESC, HDIL, Siemens; sell Arvind, Ajanta Pharma

      Bull's Eye: Buy CESC, HDIL, Siemens; sell Arvind, Ajanta Pharma

      Ruchit Jain of Angel Broking advises selling Arvind Future with a target of Rs 274.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347